A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HRS-7535 Tablets in Subjects With Overweight or Obesity
Latest Information Update: 05 May 2025
At a glance
- Drugs HRS-7535 (Primary)
- Indications Obesity
- Focus Registrational; Therapeutic Use
- Sponsors Shandong Suncadia Medicine
Most Recent Events
- 22 Apr 2025 Status changed from not yet recruiting to recruiting.
- 04 Apr 2025 New trial record